Easywell Biomedicals, Inc. (1799.TWO)

TWD 56.5

(0.0%)

EBITDA Summary of Easywell Biomedicals, Inc.

  • Easywell Biomedicals, Inc.'s latest annual EBITDA in 2023 was -85.5 Million TWD , down -1.21% from previous year.
  • Easywell Biomedicals, Inc.'s latest quarterly EBITDA in 2024 Q2 was 5.11 Million TWD , up 111.81% from previous quarter.
  • Easywell Biomedicals, Inc. reported an annual EBITDA of -84.48 Million TWD in 2022, down -2.15% from previous year.
  • Easywell Biomedicals, Inc. reported an annual EBITDA of -82.69 Million TWD in 2021, up 3.63% from previous year.
  • Easywell Biomedicals, Inc. reported a quarterly EBITDA of 5.11 Million TWD for 2024 Q2, up 111.81% from previous quarter.
  • Easywell Biomedicals, Inc. reported a quarterly EBITDA of -32.25 Million TWD for 2023 Q4, down -118.34% from previous quarter.

Annual EBITDA Chart of Easywell Biomedicals, Inc. (2023 - 2019)

Created with Highcharts 11.1.0YearsEBITDA20192019.520202020.520212021.520222022.52023-175000000 TWD-150000000 TWD-125000000 TWD-100000000 TWD-75000000 TWD

Historical Annual EBITDA of Easywell Biomedicals, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -85.5 Million TWD -1.21%
2022 -84.48 Million TWD -2.15%
2021 -82.69 Million TWD 3.63%
2020 -85.81 Million TWD 42.46%
2019 -161.91 Million TWD 0.0%

Peer EBITDA Comparison of Easywell Biomedicals, Inc.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 141.75%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 136.998%
TTY Biopharm Company Limited 1.52 Billion TWD 105.609%
Synmosa Biopharma Corporation 1 Billion TWD 108.476%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 114.667%
Center Laboratories, Inc. -175.17 Million TWD 51.19%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD 375.383%
Orient Pharma Co., Ltd. 172.39 Million TWD 149.596%
InnoPharmax Inc. -62.12 Million TWD -37.638%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 167.495%
Excelsior Biopharma Inc. -29.36 Million TWD -191.127%
DV Biomed Co., Ltd. 407.64 Million TWD 120.975%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 90.627%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 110.651%
UniPharma Co., Ltd. -16.25 Million TWD -426.031%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 165.114%
Alar Pharmaceuticals Inc. 394.52 Million TWD 121.672%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 137.447%
Mercury Biopharmaceutical Corporation -39.03 Million TWD -119.042%
Bioray Biotech Co., Ltd 12.13 Million TWD 804.582%
TSH Biopharm Corporation Limited 99.35 Million TWD 186.06%